Nick Ede still shown as part of Management team, you would think that this would have been updated by now if he has left his position.
Dr Nick Ede | Head of Corporate DevelopmentDr Nick Ede has over 30 years’ peptide vaccine and drug development experience. He was formerly CEO of globally recognised peptide and drug development service company Mimotopes Pty Ltd. Prior to that he was VP Chemistry at Chiron Corp (now Novartis) heading medicinal and combinatorial chemistry programs, and was a Research Fellow with the CRC for Vaccine Technology pioneering infectious disease and cancer peptide vaccines.
DYOR opinion only
Why IMU is a multi multi bagger, page-25340
Add IMU (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
4.8¢ |
Change
-0.002(4.00%) |
Mkt cap ! $356.9M | |||
| Open | High | Low | Value | Volume |
| 5.0¢ | 5.0¢ | 4.8¢ | $382.1K | 7.853M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 62 | 8072405 | 4.8¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 4.9¢ | 668099 | 5 |
View Market Depth
| Last trade - 16.10pm 03/10/2024 (20 minute delay) ? |
| IMU (ASX) Chart |